Selpercatinib
Spezifikationen
2152628-33-4CAS-Nummer
843-660-2EG-Nummer
6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrileIUPAC-Name
C29H31N7O3Chemische Formel
525.6 g/molMolekulargewicht
Selpercatinib; 2152628-33-4; Retevmo; 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile; CEGM9YBNGD; LY3527723; Ret inhibitor loxo-292; DTXSID901026442; WHO 10967; 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyridin-3-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile; LY-3527723; 6-(2-hydroxy-2-methylpropoxy)-4-(6-{6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl}pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile; 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitrile; Pyrazolo(1,5-a)pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxy-3-pyridinyl)methyl)-3,6-diazabicyclo(3.1.1)hept-3-yl)-3-pyridinyl)-; selpercatinibum; RefChem:58689; RET Kinase Inhibitor LOXO-292; DTXCID001510634; 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril; 843-660-2; Loxo-292; LOXO292; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; US10112942, Example 166; Selpercatinib [INN]; Selpercatinib [USAN]; Serpercatinib; Retevmo (TN); MFCD31814089; UNII-CEGM9YBNGD; Selpercatinib (Standard); LOXO-292; Selpercatinib; Selpercatinib [USAN:INN]; Selpercatinib(LOXO-292); Selpercatinib (LOXO-292); Selpercatinib(LOXO-292)?; orb1299110; CHEMBL4559134; SCHEMBL20071478; SCHEMBL29349774; SCHEMBL29362388; Selpercatinib (JAN/USAN/INN); GTPL10318; CPD2206; BDBM296429; BDBM296432; GLXC-21357; GLXC-21860; HMS5086P13; EX-A2859; EBC-27276; NSC818434; s8781; ZB1574; US10112942, Example 163; US10112942, Example 183; AKOS037649115; HY-114370R; NSC-818434; AC-31588; BP-44049; BS-16622; DA-57785; Selpercatinib (LOXO-292, ARRY-192); example 163 [WO2018071447A1]; HY-114370; CS-0084279; T8222; D11713; D77980; EN300-27032767; 6-(2-hydroxy-2- methylpropoxy)-4-(6- (6-((5- methoxypyridin-2- yl)methyl)-3,6- diazabicyclo[3.1.1] heptan-3-yl)pyridin-3- yl)pyrazolo[1,5- a]pyridine-3- carbonitrile; 6-(2-hydroxy-2-methyl-propoxy)-4-[6-[6-[(6-methoxy-3-pyridyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; Selpercatinib; Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]-; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hepSynonyme
Produkte, die Selpercatinib enthalten
레테브모정80밀리그램(셀퍼카티닙)레테브모정40밀리그램(셀퍼카티닙)레테브모캡슐40밀리그램(셀퍼카티닙)레테브모캡슐80밀리그램(셀퍼카티닙)RETSEVMO 80 MG CAPSULAS DURASRETSEVMO 40 MG CAPSULAS DURASRETSEVMO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULARETSEVMO 80 mg CAPSULAS DURASRETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULARETSEVMO 40 mg CAPSULAS DURASRETSEVMO 80 mg, géluleRETSEVMO 80 mg, comprimé pelliculé
Seite 1 von 2
